The Burden and Trends of Degenerative Mitral Valve Disease at the Global, Regional, and National Levels From 1990 to 2021, With Projections to 2035

Qiang Li; Yifan Yang; Zhi-Nan Lu; Xunan Guo; Xinmin Liu; Zhengming Jiang; Wenhui Wu; Chengqian Yin; Jianxin Li; Xiangfeng Lu; Guangyuan Song

doi:10.5334/gh.1489

The Burden and Trends of Degenerative Mitral Valve Disease at the Global, Regional, and National Levels From 1990 to 2021, With Projections to 2035

Volume 20 (2025): Issue 1

By: Qiang Li , Yifan Yang , Zhi-Nan Lu, Xunan Guo , Xinmin Liu, Zhengming Jiang, Wenhui Wu, Chengqian Yin, Jianxin Li , Xiangfeng Lu and Guangyuan Song

Open Access

|Oct 2025

Abstract

Background: Degenerative mitral valve disease (DMVD) is a significant contributor to the global burden of disease. This study aimed to estimate the prevalence, mortality, and disability-adjusted life years (DALYs) rates of DMVD at global, regional, and national levels from 1990 to 2021 and to project its future burden.

Methods: This study extracted three pivotal indicators, including the prevalence, mortality, and DALYs related to DMVD, from the Global Burden of Disease 2021. The average annual percentage change and rate change were utilized to evaluate the changes in the disease burden. Decomposition analyses were conducted to evaluate these changes. In addition, a Bayesian age-period-cohort analysis was performed to forecast the future burden of DMVD.

Results: In 2021, the global age-standardized prevalence rates (ASPRs), age-standardized mortality rates (ASMRs), and age-standardized disability-adjusted life year rates (ASDRs) for DMVD were 182.13 per 100,000 persons [95% uncertainty interval (UI): 169.952, 196.070], 0.456 per 100,000 persons (95% UI: 0.394, 0.514), and 11.362 per 100,000 persons (95% UI: 9.867, 13.611), respectively. Regions with a high sociodemographic index exhibited the most substantial disease burden. Women exhibited lower ASPR than men, but higher ASMR. Decomposition analyses reveal that improvements in DMVD burden were primarily attributable to epidemiological changes; however, it was negatively affected by population growth and aging. Predictive analysis suggests that global projections for DMVD in 2035 estimate approximately 21.41 million (95% UI: 15,718,776, 27,102,848) cases of prevalence, 47,878 (95% UI: 28,449, 67,307) cases of mortality, and 1.20 million (95% UI: 793,487, 1,615,972) cases of DALYs.

Conclusions: The global burden of DMVD, indicated in its age-standardized prevalence, mortality, and DALYs rates, exhibits significant declines. However, significant regional and national variations exist. Findings of our study emphasize the importance of devising targeted public health strategies tailored to different regions, countries, and populations, with the aim of further mitigating DMVD’s global impact.

References

Coffey S, Roberts-Thomson R, Brown A, et al. Global epidemiology of valvular heart disease. Nature Reviews Cardiology. 2021;18(12):853–864. DOI: 10.1038/s41569-021-00570-z
Open DOI Search in Google Scholar Back to article
Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: Update from the GBD 2019 study. Journal of the American College of Cardiology. 2020;76(25):2982–3021. DOI: 10.1016/j.jacc.2020.11.010
Open DOI Search in Google Scholar Back to article
Vaduganathan M, Mensah GA, Turco JV, et al. The global burden of cardiovascular diseases and risk: A compass for future health. Journal of the American College of Cardiology. 2022;80(25):2361–2371. DOI: 10.1016/j.jacc.2022.11.005
Open DOI Search in Google Scholar Back to article
Anyanwu AC, Adams DH. Etiologic classification of degenerative mitral valve disease: Barlow’s disease and fibroelastic deficiency. Seminars in Thoracic and Cardiovascular Surgery. 2007;19(2):90–96. DOI: 10.1053/j.semtcvs.2007.04.002
Open DOI Search in Google Scholar Back to article
Basso C, Perazzolo Marra M. Mitral annulus disjunction: Emerging role of myocardial mechanical stretch in arrhythmogenesis. Journal of the American College of Cardiology. 2018;72(14):1610–1612. DOI: 10.1016/j.jacc.2018.07.069
Open DOI Search in Google Scholar Back to article
Sabbag A, Essayagh B, Barrera JDR, et al. EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex in collaboration with the ESC Council on valvular heart disease and the European Association of Cardiovascular Imaging endorsed by the Heart Rhythm Society, by the Asia Pacific Heart Rhythm Society, and by the Latin American Heart Rhythm Society. Europace. 2022;24(12):1981–2003. DOI: 10.1093/europace/euac125
Open DOI Search in Google Scholar Back to article
van Wijngaarden AL, Kruithof BPT, Vinella T, et al. Characterization of degenerative mitral valve disease: Differences between fibroelastic deficiency and Barlow’s disease. Journal of Cardiovascular Development and Disease. 2021;8(2):23. DOI: 10.3390/jcdd8020023
Open DOI Search in Google Scholar Back to article
Abramowitz Y, Jilaihawi H, Chakravarty T, et al. Mitral annulus calcification. Journal of the American College of Cardiology. 2015;66(17):1934–1941. DOI: 10.1016/j.jacc.2015.08.872
Open DOI Search in Google Scholar Back to article
Fornes P, Heudes D, Fuzellier JF, et al. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: A histomorphometric study of 130 excised segments. Cardiovascular Pathology. 1999;8(2):81–92. DOI: 10.1016/S1054-8807(98)00021-0
Open DOI Search in Google Scholar Back to article
Iung B, Vahanian A. Epidemiology of valvular heart disease in the adult. Nature Reviews Cardiology. 2011;8(3):162–172. DOI: 10.1038/nrcardio.2010.202
Open DOI Search in Google Scholar Back to article
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. European Heart Journal. 2003;24(13):1231–1243. DOI: 10.1016/S0195-668X(03)00201-X
Open DOI Search in Google Scholar Back to article
GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnationallocations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England). 2024;403(10440):2133–2161. DOI: 10.1016/S0140-6736(24)00757-8
Open DOI Search in Google Scholar Back to article
GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England). 2024;403(10440):2100–2132. DOI: 10.1016/S0140-6736(24)00367-2
Open DOI Search in Google Scholar Back to article
GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet (London, England). 2024;403(10440):2162–2203. DOI: 10.1016/S0140-6736(24)00933-4
Open DOI Search in Google Scholar Back to article
Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine. 2000;19(3):335–351. DOI: 10.1002/(SICI)1097-0258(20000215)19:3<;335::AID-SIM336>3.3.CO;2-Q
Open DOI Search in Google Scholar Back to article
Das Gupta P. Standardization and decomposition of rates from cross-classified data. Genus. 1994;50(3–4):171–196.
Search in Google Scholar Back to article
Holford TR. The estimation of age, period and cohort effects for vital rates. Biometrics. 1983;39(2):311–324. DOI: 10.2307/2531004
Open DOI Search in Google Scholar Back to article
Møller B, Fekjaer H, Hakulinen T, et al. Prediction of cancer incidence in the Nordic countries: Empirical comparison of different approaches. Statistics in Medicine. 2003;22(17):2751–2766. DOI: 10.1002/sim.1481
Open DOI Search in Google Scholar Back to article
Jürgens V, Ess S, Cerny T, et al. A Bayesian generalized age-period-cohort power model for cancer projections. Statistics in Medicine. 2014;33(26):4627–4636. DOI: 10.1002/sim.6248
Open DOI Search in Google Scholar Back to article
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2014;63(22):2438–2488. DOI: 10.1016/j.jacc.2014.02.537
Open DOI Search in Google Scholar Back to article
Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2017;70(2):252–289. DOI: 10.1016/j.jacc.2017.03.011
Open DOI Search in Google Scholar Back to article
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2021;77(4):450–500. DOI: 10.1016/j.jacc.2020.11.035
Open DOI Search in Google Scholar Back to article
Stone GW, Abraham WT, Lindenfeld J, et al. Five-year follow-up after transcatheter repair of secondary mitral regurgitation. The New England Journal of Medicine. 2023;388(22):2037–2048. DOI: 10.1056/NEJMoa2300213
Open DOI Search in Google Scholar Back to article
Makkar RR, Chikwe J, Chakravarty T, et al. Transcatheter mitral valve repair for degenerative mitral regurgitation. JAMA. 2023;329(20):1778–1788. DOI: 10.1001/jama.2023.7089
Open DOI Search in Google Scholar Back to article
Suri RM, Schaff HV, Dearani JA, et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. The Annals of Thoracic Surgery. 2006;82(3):819–826. DOI: 10.1016/j.athoracsur.2006.03.091
Open DOI Search in Google Scholar Back to article
Mantovani F, Clavel MA, Michelena HI, et al. Comprehensive imaging in women with organic mitral regurgitation: Implications for clinical outcome. JACC Cardiovascular Imaging. 2016;9(4):388–396. DOI: 10.1016/j.jcmg.2016.02.017
Open DOI Search in Google Scholar Back to article
Vakamudi S, Jellis C, Mick S, et al. Sex differences in the etiology of surgical mitral valve disease. Circulation. 2018;138(16):1749–1751. DOI: 10.1161/CIRCULATIONAHA.118.035789
Open DOI Search in Google Scholar Back to article
Kislitsina ON, Zareba KM, Bonow RO, et al. Is mitral valve disease treated differently in men and women? European Journal of Preventive Cardiology. 2019;26(13):1433–1443. DOI: 10.1177/2047487319833307
Open DOI Search in Google Scholar Back to article
Vassileva CM, McNeely C, Mishkel G, et al. Gender differences in long-term survival of Medicare beneficiaries undergoing mitral valve operations. The Annals of Thoracic Surgery. 2013;96(4):1367–1373. DOI: 10.1016/j.athoracsur.2013.04.055
Open DOI Search in Google Scholar Back to article
Elmariah S, Budoff MJ, Delaney JA, et al. Risk factors associated with the incidence and progression of mitral annulus calcification: The multi-ethnic study of atherosclerosis. American Heart Journal. 2013;166(5):904–912. DOI: 10.1016/j.ahj.2013.08.015
Open DOI Search in Google Scholar Back to article
NCD Countdown 2030 Collaborators. NCD countdown 2030: Worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet (London, England). 2018;392(10152):1072–1088. DOI: 10.1016/S0140-6736(18)31992-5
Open DOI Search in Google Scholar Back to article
NCD Countdown 2030 Collaborators. NCD Countdown 2030: Efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries. Lancet (London, England). 2022;399(10331):1266–1278. DOI: 10.1016/S0140-6736(21)02347-3
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.5334/gh.1489 | Journal eISSN: 2211-8179

Journal RSS Feed

Language: English

Submitted on: Feb 10, 2025

Accepted on: Oct 8, 2025

Published on: Oct 28, 2025

Published by: Ubiquity Press

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

Degenerative mitral valve disease,

Global burden of disease,

Prevalence,

Mortality,

Disability-adjusted life years

© 2025 Qiang Li, Yifan Yang, Zhi-Nan Lu, Xunan Guo, Xinmin Liu, Zhengming Jiang, Wenhui Wu, Chengqian Yin, Jianxin Li, Xiangfeng Lu, Guangyuan Song, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 20 (2025): Issue 1